patients receiving neuromuscular blocking agents required for their clinical care during a surgical procedure
Conditions
Interventions
As this is an observational trial, no additional interventions will be done.
Sponsors
university medical center groningen
Eligibility
Inclusion criteria
Inclusion criteria: - Age 18 years or older; - Subject meets the American Society of Anesthesiology (ASA) physical status I-III criteria (Table I); - Subject has provided written informed consent.
Exclusion criteria
Exclusion criteria: - Presence of an underlying neuromuscular disease - Presence of renal or hepatic disease - Subject has open skin sores at locations needed for electrode application - Patient taking the following medication: - anti-seizure medication - anti-cholinestase medication - magnesium sulfate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of this study is to provide EMG performance data of the TetraGraph device on anesthetized subjects. Performance will be assessed post hoc by analyzing objective EMG data and correlating with the responses to annotations made during the surgical procedure (e.g., correlating the EMG responses to the time of NMBA administration). | — |
Secondary
| Measure | Time frame |
|---|---|
| o Investigating the quality of the applied skin electrodes (clinically available 3M Red Dot electrodes) o Observing the applicability of the prototype (easy of use, …) | — |
Contacts
Public ContactR. Spanjersberg
Hanzeplein 1
Outcome results
None listed